Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	group III metabotropic glutamate receptor activity	GRM6 GRM7	1.48e-04	4	100	2	GO:0001642
GeneOntologyMolecularFunction	single-stranded DNA helicase activity	MCM6 CHTF8 CHTF18	2.01e-04	23	100	3	GO:0017116
GeneOntologyMolecularFunction	DNA helicase activity	MCM6 RUVBL2 CHTF8 CHTF18	2.64e-04	62	100	4	GO:0003678
GeneOntologyMolecularFunction	glutamate receptor activity	GRIN2A GRM6 GRM7	3.27e-04	27	100	3	GO:0008066
GeneOntologyBiologicalProcess	detection of mechanical stimulus	GRIN2A PJVK PKD1 SCN10A STRC STRCP1	1.62e-06	75	99	6	GO:0050982
GeneOntologyBiologicalProcess	detection of mechanical stimulus involved in sensory perception	GRIN2A PJVK SCN10A STRC STRCP1	7.90e-06	57	99	5	GO:0050974
GeneOntologyBiologicalProcess	detection of external stimulus	GRIN2A GRM6 PJVK PKD1 SCN10A STRC STRCP1	2.01e-05	173	99	7	GO:0009581
GeneOntologyBiologicalProcess	detection of abiotic stimulus	GRIN2A GRM6 PJVK PKD1 SCN10A STRC STRCP1	2.17e-05	175	99	7	GO:0009582
GeneOntologyBiologicalProcess	inner ear receptor cell differentiation	FAT4 PJVK STRC USH2A STRCP1	9.95e-05	96	99	5	GO:0060113
GeneOntologyBiologicalProcess	inner ear receptor cell stereocilium organization	FAT4 PJVK STRC STRCP1	1.22e-04	53	99	4	GO:0060122
GeneOntologyBiologicalProcess	mechanoreceptor differentiation	FAT4 PJVK STRC USH2A STRCP1	1.45e-04	104	99	5	GO:0042490
GeneOntologyBiologicalProcess	sensory perception of mechanical stimulus	GRIN2A GRM7 PJVK SCN10A STRC USH2A STRCP1	1.51e-04	238	99	7	GO:0050954
GeneOntologyBiologicalProcess	detection of mechanical stimulus involved in sensory perception of sound	PJVK STRC STRCP1	1.77e-04	23	99	3	GO:0050910
GeneOntologyBiologicalProcess	glutamate receptor signaling pathway	GRIN2A GRM6 GRM7 TIAM1	1.86e-04	59	99	4	GO:0007215
GeneOntologyBiologicalProcess	response to mechanical stimulus	GRIN2A PTCH1 PJVK PKD1 SCN10A STRC STRCP1	1.89e-04	247	99	7	GO:0009612
GeneOntologyBiologicalProcess	sensory organ development	FAT4 CYP26B1 MYOM1 GRM6 FREM2 LIM2 FAT1 PJVK MYOM2 STRC USH2A STRCP1	1.95e-04	730	99	12	GO:0007423
GeneOntologyBiologicalProcess	positive regulation of glycogen metabolic process	INSR PHKA1 INS-IGF2	2.02e-04	24	99	3	GO:0070875
GeneOntologyBiologicalProcess	extraocular skeletal muscle development	MYOM1 MYOM2	2.26e-04	5	99	2	GO:0002074
GeneOntologyBiologicalProcess	dendritic spine organization	CUX2 INSR GRIN2A TIAM1 INS-IGF2	2.33e-04	115	99	5	GO:0097061
GeneOntologyBiologicalProcess	response to wounding	GPR4 EPPK1 WDR83 EVPL GRIN2A BNIP3 FIBP PARD3 HPS5 INS-IGF2 VAV2	3.21e-04	659	99	11	GO:0009611
GeneOntologyCellularComponent	9+2 non-motile cilium	TIAM1 STRC STRCP1	3.61e-05	14	99	3	GO:0097732
GeneOntologyCellularComponent	kinocilium	TIAM1 STRC STRCP1	3.61e-05	14	99	3	GO:0060091
GeneOntologyCellularComponent	stereocilium bundle	TIAM1 PJVK STRC USH2A STRCP1	3.67e-05	79	99	5	GO:0032421
GeneOntologyCellularComponent	stereocilium	PJVK STRC USH2A STRCP1	3.23e-04	69	99	4	GO:0032420
GeneOntologyCellularComponent	somatodendritic compartment	DIP2B ANK3 INSR GRIN2A PTCH1 CPNE5 GRM6 GRM7 NPTN BNIP3 TIAM1 PJVK PARD3 USH2A HNRNPR	6.46e-04	1228	99	15	GO:0036477
Domain	fn3	COL7A1 MYOM1 INSR ROS1 MYOM2 USH2A	2.12e-04	162	98	6	PF00041
Domain	Cadherin	FAT4 PCDHA7 FREM3 FREM2 FAT1	3.93e-04	118	98	5	IPR002126
Domain	-	EPPK1 EVPL	4.03e-04	6	98	2	3.90.1290.10
Domain	FN3	COL7A1 MYOM1 INSR ROS1 MYOM2 USH2A	4.31e-04	185	98	6	SM00060
Domain	Plectin_repeat	EPPK1 EVPL	5.63e-04	7	98	2	IPR001101
Domain	Plectin	EPPK1 EVPL	5.63e-04	7	98	2	PF00681
Domain	PLEC	EPPK1 EVPL	5.63e-04	7	98	2	SM00250
Domain	FN3	COL7A1 MYOM1 INSR ROS1 MYOM2 USH2A	6.33e-04	199	98	6	PS50853
Domain	Calx_beta	FREM3 FREM2	7.48e-04	8	98	2	SM00237
Domain	GPCR_3_mtglu_rcpt	GRM6 GRM7	7.48e-04	8	98	2	IPR000162
Domain	FN3_dom	COL7A1 MYOM1 INSR ROS1 MYOM2 USH2A	8.18e-04	209	98	6	IPR003961
Domain	ANF_lig-bd_rcpt	GRIN2A GRM6 GRM7	9.56e-04	37	98	3	IPR001828
Domain	ANF_receptor	GRIN2A GRM6 GRM7	9.56e-04	37	98	3	PF01094
Domain	Calx_beta	FREM3 FREM2	9.58e-04	9	98	2	IPR003644
Domain	Calx-beta	FREM3 FREM2	9.58e-04	9	98	2	PF03160
Domain	LAM_G_DOMAIN	FAT4 FAT1 USH2A	1.03e-03	38	98	3	PS50025
Domain	Peripla_BP_I	GRIN2A GRM6 GRM7	1.12e-03	39	98	3	IPR028082
Domain	Amino_oxidase	MAOA SMOX	1.19e-03	10	98	2	IPR002937
Domain	Amino_oxidase	MAOA SMOX	1.19e-03	10	98	2	PF01593
Domain	Laminin_G_2	FAT4 FAT1 USH2A	1.20e-03	40	98	3	PF02210
Domain	Tyr_kinase_rcpt_2_CS	INSR ROS1	1.45e-03	11	98	2	IPR002011
Domain	LamG	FAT4 FAT1 USH2A	1.59e-03	44	98	3	SM00282
Domain	RECEPTOR_TYR_KIN_II	INSR ROS1	1.74e-03	12	98	2	PS00239
Domain	NCD3G	GRM6 GRM7	2.05e-03	13	98	2	PF07562
Domain	GPCR_3_9-Cys_dom	GRM6 GRM7	2.05e-03	13	98	2	IPR011500
Domain	6-hairpin_glycosidase-like	PHKA1 AGL	2.05e-03	13	98	2	IPR008928
Domain	GPCR_3_CS	GRM6 GRM7	2.38e-03	14	98	2	IPR017979
Domain	CA	FAT4 PCDHA7 FREM2 FAT1	3.16e-03	115	98	4	SM00112
Domain	-	MAOA MTO1 SMOX	3.17e-03	56	98	3	3.50.50.60
Domain	FAD/NAD-binding_dom	MAOA MTO1 SMOX	3.34e-03	57	98	3	IPR023753
Domain	C1_1	MYO9B CHN2 VAV2	3.34e-03	57	98	3	PF00130
Domain	Laminin_G	FAT4 FAT1 USH2A	3.51e-03	58	98	3	IPR001791
Domain	ZF_DAG_PE_1	MYO9B CHN2 VAV2	4.63e-03	64	98	3	PS00479
Domain	ZF_DAG_PE_2	MYO9B CHN2 VAV2	4.63e-03	64	98	3	PS50081
Domain	C1	MYO9B CHN2 VAV2	4.84e-03	65	98	3	SM00109
Domain	PE/DAG-bd	MYO9B CHN2 VAV2	5.05e-03	66	98	3	IPR002219
Pubmed	Spatiotemporal distribution of Fras1/Frem proteins during mouse embryonic development.	COL7A1 FREM3 FREM2	2.30e-07	5	100	3	17251066
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SIN3B FAT4 CYP26B1 EVPL FREM2 FBXL7 GTF3C1 H4C1 DROSHA AGL PKD1 HNRNPR	1.42e-06	736	100	12	29676528
Pubmed	Mutation of ARHGAP9 in patients with coronary spastic angina.	MYO9B CHN2 TIAM1 VAV2	4.41e-06	38	100	4	19911011
Pubmed	Protein kinase D activation stimulates the transcription of the insulin receptor gene.	INSR PKD1	8.18e-06	2	100	2	20674666
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	8.18e-06	2	100	2	34910522
Pubmed	Severe insulin resistance and intrauterine growth deficiency associated with haploinsufficiency for INSR and CHN2: new insights into synergistic pathways involved in growth and metabolism.	INSR CHN2	8.18e-06	2	100	2	19720790
Pubmed	Tetrodotoxin-resistant voltage-gated sodium channel Nav 1.8 constitutively interacts with ankyrin G.	ANK3 SCN10A	8.18e-06	2	100	2	24903831
Pubmed	The Par-Tiam1 complex controls persistent migration by stabilizing microtubule-dependent front-rear polarity.	TIAM1 PARD3	8.18e-06	2	100	2	17825562
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	8.18e-06	2	100	2	11687802
Pubmed	Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1.	TIAM1 PARD3	8.18e-06	2	100	2	26084985
Pubmed	Fat1 interacts with Fat4 to regulate neural tube closure, neural progenitor proliferation and apical constriction during mouse brain development.	FAT4 FAT1 PARD3	1.82e-05	18	100	3	26209645
Pubmed	Insulin protects acinar cells during pancreatitis by preserving glycolytic ATP supply to calcium pumps.	INSR INS-IGF2	2.45e-05	3	100	2	34282152
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	2.45e-05	3	100	2	30801007
Pubmed	Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysis.	INSR INS-IGF2	2.45e-05	3	100	2	29512653
Pubmed	Replication of genetic variation in the MYO9B gene in Crohn's disease.	MYO9B PARD3	2.45e-05	3	100	2	21515326
Pubmed	Alternative splicing variants of proinsulin mRNA and the effects of excess proinsulin on cardiac morphogenesis.	INSR INS-IGF2	2.45e-05	3	100	2	23747309
Pubmed	Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability.	MYO9B PARD3	2.45e-05	3	100	2	20096742
Pubmed	Mutations in the C1 element of the insulin promoter lead to diabetic phenotypes in homozygous mice.	INSR INS-IGF2	2.45e-05	3	100	2	32546815
Pubmed	All-atom structural models of insulin binding to the insulin receptor in the presence of a tandem hormone-binding element.	INSR INS-IGF2	2.45e-05	3	100	2	23348915
Pubmed	Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.	ANK3 TIAM1	2.45e-05	3	100	2	10893266
Pubmed	The globular head domain of titin extends into the center of the sarcomeric M band. cDNA cloning, epitope mapping and immunoelectron microscopy of two titin-associated proteins.	MYOM1 MYOM2	2.45e-05	3	100	2	7505783
Pubmed	Expression of Fraser syndrome genes in normal and polycystic murine kidneys.	FREM3 FREM2	2.45e-05	3	100	2	21993971
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	EPPK1 PFAS MCM6 CCT4 GMPR2 RUVBL2 GTF3C1 AGL POLR1B TBC1D23	3.65e-05	704	100	10	29955894
Pubmed	Glutamate can act as a signaling molecule in mouse preimplantation embryos†.	GRIN2A GRM6 GRM7	4.47e-05	24	100	3	35746896
Pubmed	Stereocilin-deficient mice reveal the origin of cochlear waveform distortions.	STRC STRCP1	4.89e-05	4	100	2	18849963
Pubmed	Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src.	TIAM1 VAV2	4.89e-05	4	100	2	12810717
Pubmed	Nestin is expressed during development and in myotendinous and neuromuscular junctions in wild type and desmin knock-out mice.	MYOM1 MYOM2	4.89e-05	4	100	2	10438587
Pubmed	Differential localization profile of Fras1/Frem proteins in epithelial basement membranes of newborn and adult mice.	FREM3 FREM2	4.89e-05	4	100	2	18563433
Pubmed	Distribution of group-III metabotropic glutamate receptors in the retina.	GRM6 GRM7	4.89e-05	4	100	2	17311335
Pubmed	Segmental and restricted localization pattern of Fras1 in the developing meningeal basement membrane in mouse.	FREM3 FREM2	4.89e-05	4	100	2	24101214
Pubmed	Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation.	INSR INS-IGF2	4.89e-05	4	100	2	26511317
Pubmed	Arteries define the position of the thyroid gland during its developmental relocalisation.	FOXE1 PTCH1	4.89e-05	4	100	2	16968815
Pubmed	Muscle-type creatine kinase interacts with central domains of the M-band proteins myomesin and M-protein.	MYOM1 MYOM2	4.89e-05	4	100	2	12972258
Pubmed	Insulin-InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages.	INSR INS-IGF2	4.89e-05	4	100	2	26573296
Pubmed	Beta-cell specific Insr deletion promotes insulin hypersecretion and improves glucose tolerance prior to global insulin resistance.	INSR INS-IGF2	4.89e-05	4	100	2	35136059
Pubmed	A second proliferating cell nuclear antigen loader complex, Ctf18-replication factor C, stimulates DNA polymerase eta activity.	CHTF8 CHTF18	4.89e-05	4	100	2	17545166
Pubmed	The PHCCEx domain of Tiam1/2 is a novel protein- and membrane-binding module.	TIAM1 PARD3	4.89e-05	4	100	2	19893486
Pubmed	Par-3 controls tight junction assembly through the Rac exchange factor Tiam1.	TIAM1 PARD3	4.89e-05	4	100	2	15723052
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	TRA2B MYO9B INSR PFAS MCM6 CCT4 RUVBL2 ERAP2 H4C1 CHTF18 DOT1L PARD3 HNRNPR	6.00e-05	1247	100	13	27684187
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	ISYNA1 TRA2B FBXL12 PFAS MCM6 CCT4 RUVBL2 GTF3C1 H4C1 CHTF18 AGL POLR1B HNRNPR	6.50e-05	1257	100	13	37317656
Pubmed	Myomesin 3, a novel structural component of the M-band in striated muscle.	MYOM1 MYOM2	8.14e-05	5	100	2	18177667
Pubmed	Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects.	INSR INS-IGF2	8.14e-05	5	100	2	18056790
Pubmed	Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice.	INSR INS-IGF2	8.14e-05	5	100	2	15924147
Pubmed	Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly.	FAT4 FAT1	8.14e-05	5	100	2	30862798
Pubmed	Insulin signaling to the glomerular podocyte is critical for normal kidney function.	INSR INS-IGF2	8.14e-05	5	100	2	20889126
Pubmed	Rap1 promotes cell spreading by localizing Rac guanine nucleotide exchange factors.	TIAM1 VAV2	8.14e-05	5	100	2	15479739
Pubmed	Genetic risk for restenosis after coronary stenting.	INSR ROS1	8.14e-05	5	100	2	17275003
Pubmed	Selective gene activation by spatial segregation of insulin receptor B signaling.	INSR INS-IGF2	8.14e-05	5	100	2	17264162
Pubmed	Impaired insulin/IGF-1 is responsible for diabetic gastroparesis by damaging myenteric cholinergic neurones and interstitial cells of Cajal.	INSR INS-IGF2	8.14e-05	5	100	2	28931726
Pubmed	Glucose, insulin, insulin receptor subunits α and β in normal and spontaneously diabetic and obese ob/ob and db/db infertile mouse testis and hypophysis.	INSR INS-IGF2	8.14e-05	5	100	2	32183843
Pubmed	The Akt substrate Girdin is a regulator of insulin signaling in myoblast cells.	INSR INS-IGF2	8.14e-05	5	100	2	23886629
Pubmed	An unusually powerful mode of low-frequency sound interference due to defective hair bundles of the auditory outer hair cells.	STRC STRCP1	8.14e-05	5	100	2	24920589
Pubmed	Basement membrane localization of Frem3 is independent of the Fras1/Frem1/Frem2 protein complex within the sublamina densa.	FREM3 FREM2	8.14e-05	5	100	2	17596926
Pubmed	Absence of canonical Smad signaling in ureteral and bladder mesenchyme causes ureteropelvic junction obstruction.	COL7A1 MYOM1 MYOM2	9.78e-05	31	100	3	22282597
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DIP2B PFAS RUVBL2 FREM2 GTF3C1 DROSHA CHTF18 ANAPC2 HPS5	1.11e-04	650	100	9	38777146
Pubmed	Pias1 interaction and sumoylation of metabotropic glutamate receptor 8.	GRM6 GRM7	1.22e-04	6	100	2	16144832
Pubmed	Establishment of cardiac cytoarchitecture in the developing mouse heart.	MYOM1 MYOM2	1.22e-04	6	100	2	16337936
Pubmed	A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.	GRIN2A SMOX	1.22e-04	6	100	2	23665428
Pubmed	Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.	FOXE1 EVPL	1.22e-04	6	100	2	27207655
Pubmed	Frem3, a member of the 12 CSPG repeats-containing extracellular matrix protein family, is a basement membrane protein with tissue distribution patterns distinct from those of Fras1, Frem2, and QBRICK/Frem1.	FREM3 FREM2	1.22e-04	6	100	2	17462874
Pubmed	Central insulin action regulates peripheral glucose and fat metabolism in mice.	INSR INS-IGF2	1.22e-04	6	100	2	18451994
Pubmed	Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation.	INSR MCM6 CCT4 RUVBL2 H4C1 HNRNPR	1.31e-04	269	100	6	30442662
Pubmed	The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation.	PTCH1 FREM3 FREM2 PKD1	1.68e-04	95	100	4	20843830
Pubmed	Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase {epsilon} is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8.	CHTF8 CHTF18	1.70e-04	7	100	2	20826785
Pubmed	Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity.	FAT4 FAT1	1.70e-04	7	100	2	22510986
Pubmed	Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos.	INSR INS-IGF2	1.70e-04	7	100	2	1317321
Pubmed	Autoreactive T-cell receptor (Vbeta/D/Jbeta) sequences in diabetes are homologous to insulin, glucagon, the insulin receptor, and the glucagon receptor.	INSR INS-IGF2	1.70e-04	7	100	2	19051206
Pubmed	Metabotropic glutamate receptor subtype 7 ablation causes deficit in fear response and conditioned taste aversion.	GRM6 GRM7	1.70e-04	7	100	2	9920659
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT4 FAT1	1.70e-04	7	100	2	16059920
Pubmed	The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.	INSR INS-IGF2	1.70e-04	7	100	2	12488434
Pubmed	Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells.	INSR INS-IGF2	1.70e-04	7	100	2	1701096
Pubmed	Polycystin-1 binds Par3/aPKC and controls convergent extension during renal tubular morphogenesis.	PKD1 PARD3	1.70e-04	7	100	2	24153433
Pubmed	Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function.	INSR INS-IGF2	1.70e-04	7	100	2	28687614
Pubmed	Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration.	DIP2B MAOA ANK3 CCT4 RUVBL2 H4C1 AGL FIBP	2.13e-04	558	100	8	35063084
Pubmed	Bimodal distribution of RNA expression levels in human skeletal muscle tissue.	MAOA ERAP2	2.27e-04	8	100	2	21299892
Pubmed	CCM1 regulates vascular-lumen organization by inducing endothelial polarity.	TIAM1 PARD3	2.27e-04	8	100	2	20332120
Pubmed	Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane.	STRC STRCP1	2.27e-04	8	100	2	21165971
Pubmed	Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas.	PTCH1 INS-IGF2	2.27e-04	8	100	2	9368764
Pubmed	Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.	ZAP70 VAV2	2.27e-04	8	100	2	11390470
Pubmed	CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function.	MYOM1 MYOM2	2.27e-04	8	100	2	20215401
Pubmed	PHOG, a candidate gene for involvement in the short stature of Turner syndrome.	SHOX GABPB2	2.27e-04	8	100	2	9259282
Pubmed	Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor.	TIAM1 PKD1	2.27e-04	8	100	2	25907116
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	ISYNA1 EPPK1 ANK3 RUVBL2 PHKA1 VAV2	2.54e-04	304	100	6	32235678
Pubmed	Isolation of novel tissue-specific genes from cDNA libraries representing the individual tissue constituents of the gastrulating mouse embryo.	TRA2B FBXL12 MCM6 FBXL7 ANAPC2 HPS5 ATP6V0A2	2.58e-04	432	100	7	7671812
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	MYO9B INSR PTCH1 DOT1L SMOX	2.76e-04	198	100	5	20881960
Pubmed	In vitro fertilization causes epigenetic modifications to the onset of gene expression from the zygotic genome in mice.	INSR INS-IGF2	2.91e-04	9	100	2	11159375
Pubmed	GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.	PTCH1 PARD3	2.91e-04	9	100	2	23446420
Pubmed	The F-box protein Fbl10 is a novel transcriptional repressor of c-Jun.	FBXL12 FBXL7	2.91e-04	9	100	2	17704768
Pubmed	Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.	INSR ROS1	2.91e-04	9	100	2	11094073
Pubmed	Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas.	EPPK1 INS-IGF2	2.91e-04	9	100	2	18498355
Pubmed	Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.	GRIN2A GRM6 GRM7	3.00e-04	45	100	3	25979088
Pubmed	SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.	CCT4 RUVBL2 H4C1	3.20e-04	46	100	3	29969578
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FAT4 EPPK1 TRA2B PFAS TMEM214 RUVBL2 FBXL7 ROS1 VAV2	3.32e-04	754	100	9	35906200
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	DIP2B TRA2B ATP13A1 PFAS DROSHA SSH3 CHTF18 AGL PKD1 POLR1B	3.37e-04	925	100	10	28986522
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA4B EPPK1 ATP13A1 MYO9B FBXL12 PFAS PTCH1 ABCA7 FAT1 PKD1 DOT1L	3.40e-04	1105	100	11	35748872
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	RUVBL2 GTF3C1 ANAPC2 HNRNPR	3.60e-04	116	100	4	21549307
Pubmed	Genome-wide association analyses of child genotype effects and parent-of-origin effects in specific language impairment.	FOXE1 DHRS1	3.63e-04	10	100	2	24571439
Pubmed	Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.	CCT4 RUVBL2	3.63e-04	10	100	2	35821088
Pubmed	Wnt Signaling Separates the Progenitor and Endocrine Compartments during Pancreas Development.	PTCH1 INS-IGF2	3.63e-04	10	100	2	31116975
Pubmed	Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.	RUVBL2 GTF3C1	3.63e-04	10	100	2	19299493
Interaction	PHKG2 interactions	PLEKHA4 PEX10 PHKA1 TIAM1 AGL HPS5	5.41e-06	91	98	6	int:PHKG2
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	SIN3B SLC25A42 ISYNA1 ATP13A1 MYO9B INSR FBXL12 WDR83 ABCA7 DOT1L	9.98e-06	797	100	10	chr19p13
Cytoband	19p13.11	SIN3B SLC25A42 ISYNA1 ATP13A1	2.06e-05	73	100	4	19p13.11
GeneFamily	Fibronectin type III domain containing	COL7A1 MYOM1 INSR ROS1 MYOM2 USH2A	4.22e-05	160	72	6	555
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYOM1 MYOM2	4.31e-04	8	72	2	658
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 EVPL	4.31e-04	8	72	2	939
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM6 GRM7	4.31e-04	8	72	2	281
GeneFamily	Cadherin related	FAT4 FAT1	2.05e-03	17	72	2	24
GeneFamily	F-box and leucine rich repeat proteins	FBXL12 FBXL7	3.13e-03	21	72	2	558
Coexpression	JAEGER_METASTASIS_DN	COL7A1 EPPK1 CYP26B1 ANK3 EVPL PTCH1 CHN2 SSH3	7.13e-06	260	100	8	M10702
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FAT4 DOK2 HAVCR2 LIM2 GTF3C1 SSH3 MYOM2	3.15e-07	197	100	7	d2f7ba404a0340e12ccbd3f9d76c8d782584e775
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP26B1 GRIN2A FREM2 SCN10A STRC SLC2A12	1.55e-06	158	100	6	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP26B1 GRIN2A FREM2 SCN10A STRC SLC2A12	1.55e-06	158	100	6	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 MCM6 CPNE5 HAVCR2 CHTF18 PADI1	3.09e-06	178	100	6	de6cd81e6d58e7687386df163471bf1901b9c0aa
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FREM2 FAT1 ROS1 MYOM2 USH2A	3.74e-06	184	100	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FREM2 FAT1 ROS1 MYOM2 USH2A	3.74e-06	184	100	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 FREM2 FAT1 ROS1 MYOM2 USH2A	3.74e-06	184	100	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.06e-06	194	100	6	fa72c2f3e6b8bfc2ef126deb219ec6a44809385b
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.06e-06	194	100	6	bc7c4efe2a82057fb95582da983e36f413990902
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.06e-06	194	100	6	b43788e458a80ab93f485f4577370aec448ad95e
ToppCell	IIF-Lymphocyte-T_NK-NK\|IIF / Disease, Lineage and Cell Type	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.22e-06	195	100	6	464ce05cb52f78aee22d3baa6641b37bd53aae16
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.22e-06	195	100	6	acc603dc94ac6518adb0dffb43305b380ec75b52
ToppCell	T/NK_cells-CD56dim_NK_cell\|World / Lineage and Cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.22e-06	195	100	6	6124e87cb9061bf8918377fb4a79084079ddfc16
ToppCell	normal-na-Lymphocytic_NK\|normal / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.22e-06	195	100	6	cebe79c42af5910353ba9ad7d0edb01982f772a3
ToppCell	(0)_NK_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	9b080859130cf156bfa833dc71fd39734cb9a32d
ToppCell	COVID-19_Severe-Lymphoid_T/NK-NK\|COVID-19_Severe / Disease group, lineage and cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	cc1daf12de5765ba4f7002396352404b41df2012
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	d3bd8fab010e76024d7e06aba0ea5df3394f411f
ToppCell	(0)_NK\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	e2578a562d9903a33a7c60db229005680af8141c
ToppCell	normal-na-Lymphocytic_NK-NK_dim-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	61bc0d161e01f36e5bcda4d4f4693afbfe5654bb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	77da6b1bcab45d376eb0368f540e0ed24ce98b42
ToppCell	tumor_Lung-T/NK_cells-NK\|tumor_Lung / Location, Cell class and cell subclass	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	006e630f3d8033f45c6b7e9154d77000c7b0cb70
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	c25f90c4e5abfe7cfaa85bfe136c438a5179c978
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	d451f279f4086fcf727af712f98923551181c76e
ToppCell	normal-na-Lymphocytic_NK-NK_dim\|normal / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.37e-06	196	100	6	3360d96dc06241498995bcb875615bd4c1424f5a
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.53e-06	197	100	6	9993fdea353abeafc009ac87439ad25cedf8f1f6
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.53e-06	197	100	6	300849a922722adcbc068593fc5cc0bef936d9cb
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.53e-06	197	100	6	a8b41fffa4e86f2766423392951ff320e821a19a
ToppCell	T/NK_cells-CD56dim_NK_cell\|T/NK_cells / Lineage and Cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.53e-06	197	100	6	722d00a218755cc8cb7b5ab2a7fca40269247c3a
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.53e-06	197	100	6	a97c4a9eb89260b0b5745834ccef9d558d857f93
ToppCell	(0)_NK_FCGR3Apos\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.69e-06	198	100	6	13f10f9233fc1523f0da2d9d59f3ced9c51a603a
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_B\|390C / Donor, Lineage, Cell class and subclass (all cells)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.69e-06	198	100	6	0dc4a564dcab8ac42f238f98ee1f2090b0dcffe6
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-NK\|Multiple_Sclerosis / Disease, Lineage and Cell Type	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.69e-06	198	100	6	d413020012977eb8da0a5641dd16d0b0a60bec38
ToppCell	(0)_NK_cells-(0)_NK_FCGR3Apos\|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PTCH1 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.69e-06	198	100	6	eba39656c6f699ab297b652ded8cb9727b49593c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAT4 DOK2 ZAP70 HAVCR2 LIM2 MYOM2	5.69e-06	198	100	6	1a189b2b213099505c5d871fb8aedd55a97d44e0
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAT4 DOK2 ZAP70 HAVCR2 LIM2 MYOM2	5.69e-06	198	100	6	716c27d2a37b5f865b9d191e1851917340b400af
ToppCell	390C-Lymphocytic-NK_cells\|390C / Donor, Lineage, Cell class and subclass (all cells)	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.69e-06	198	100	6	872ddb2738c5e0375830bb0e5b2c50383bf58738
ToppCell	metastatic_Lymph_Node-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	5.69e-06	198	100	6	cc4c1306683b801c1cb0adc01951aa6e3d73626f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAT4 DOK2 ZAP70 HAVCR2 LIM2 MYOM2	5.69e-06	198	100	6	b12914c3c5b8dd628cb456cb40283c5016641872
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL7A1 CUX2 FREM2 TIAM1 PARD3 VAV2	6.03e-06	200	100	6	f3c710f0fc8a7bfb5371d1aff6e3d8f266953153
ToppCell	MS-IIF-Lymphocyte-T/NK-NK\|IIF / Disease, condition lineage and cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	6.03e-06	200	100	6	4f889cc5ab76a128fd781d927b0d8368f4f927b7
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL7A1 CUX2 FREM2 TIAM1 PARD3 VAV2	6.03e-06	200	100	6	70a06fd7fb8de2c8ec3e3182e4476ced049daeae
ToppCell	severe-NK\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	6.03e-06	200	100	6	64e8a6c36e0c654b7b2416c9f19b9058215222b1
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK\|COVID-19_Severe / Disease, condition lineage and cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	6.03e-06	200	100	6	2580b7b83ba707718fe23ffca986e7a55ea85bce
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-NK\|Multiple_Sclerosis / Disease, condition lineage and cell class	DOK2 ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	6.03e-06	200	100	6	d7a611d88107d84b5995b353e8cf95c6a7eb79de
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	COL7A1 CUX2 FREM2 TIAM1 PARD3 VAV2	6.03e-06	200	100	6	1639982d9d994918f7912d12d9d7cfcbc9da4145
ToppCell	distal-Epithelial-Basal-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FOXE1 SEMA4B COL7A1 ISYNA1 PLEKHA4 PNCK	6.03e-06	200	100	6	6f00d08e93f89b3575ebbd5c2f451e655d449ef3
ToppCell	BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)\|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	1.91e-05	145	100	5	6dd81d53d006fcc206a10969374a11c372f92133
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-3\|TCGA-Colorectal / Sample_Type by Project: Shred V9	WDR83 PEX10 RUVBL2 ANAPC2 NAGPA	3.45e-05	164	100	5	201aee6387e69f918d87fa87d9b5b2ab3b305f61
ToppCell	droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR4 GMPR2 TIAM1 H4C1 DOT1L	3.65e-05	166	100	5	de319c960b0cd90b294f677d1ea1b013a2ce2d53
ToppCell	NS-critical-d_0-4-Epithelial-unknown_epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	EPPK1 PLEKHA4 FBXL7 H4C1 PNCK	3.65e-05	166	100	5	dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ISYNA1 ANK3 ZAP70 MYOM2 DNAJC5B	4.45e-05	173	100	5	5295ed31648abf8edff214cf67cd4769f20f9e6d
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PRSS33 DOK2 ZAP70 HAVCR2 LIM2	5.37e-05	180	100	5	0a98d21fec67a890e75ebf0e2d23adddd77da214
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PRSS33 DOK2 ZAP70 HAVCR2 LIM2	5.37e-05	180	100	5	1c8398342d3fa4d5ca9a8a63626cc497c5291446
ToppCell	10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PRSS33 DOK2 ZAP70 HAVCR2 LIM2	5.37e-05	180	100	5	ddbab26b05f057bd78b78773381cd447bd2e2726
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CUX2 INSR GRIN2A GRM7 USH2A	5.51e-05	181	100	5	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	Control-Epithelial-Basal\|World / Disease state, Lineage and Cell class	FOXE1 COL7A1 ANK3 FAT1 PARD3	5.66e-05	182	100	5	759390dde9b18757f7675d13d44c89d0e32f8d93
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_B2\|356C / Donor, Lineage, Cell class and subclass (all cells)	DOK2 ZAP70 LIM2 GTF3C1 MYOM2	5.66e-05	182	100	5	52baef8173df0a55307c375674a37c2488066738
ToppCell	Control-Epithelial-Basal\|Control / Disease state, Lineage and Cell class	FOXE1 COL7A1 ANK3 FAT1 PARD3	5.66e-05	182	100	5	caddd0a52f0234ea6a916186ffaf2454cdcd80ee
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	FOXE1 DIP2B COL7A1 TRA2B PNCK	5.96e-05	184	100	5	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	Mild_COVID-19-Epithelial-AT1/AT2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MAOA FREM2 FAT1 CLCNKA SLC2A12	6.11e-05	185	100	5	c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCell	IPF-Epithelial-ATII\|World / Disease state, Lineage and Cell class	MAOA ANK3 FREM2 ROS1 PARD3	6.27e-05	186	100	5	6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	6.59e-05	188	100	5	a29c43a91ed1364a09d5abab6efa51b8061bce74
ToppCell	COPD-Epithelial-ATII\|COPD / Disease state, Lineage and Cell class	MAOA ANK3 FREM2 ROS1 PARD3	6.59e-05	188	100	5	eb6d79d733b53f64ca615bb777c64ed456866549
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ANK3 GRIN2A PTCH1 FREM2 FBXL7	6.59e-05	188	100	5	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FREM2 FAT1 FBXL7 TIAM1 PARD3	6.93e-05	190	100	5	2f54da2bee411f8868348a4c37034184b8f58a89
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	ANK3 MYOM1 CPNE5 FAT1 MYOM2	6.93e-05	190	100	5	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	ANK3 MYOM1 CPNE5 CHN2 MYOM2	6.93e-05	190	100	5	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	MAOA ANK3 FREM2 ROS1 PARD3	7.28e-05	192	100	5	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTCH1 ZAP70 LIM2 GTF3C1 MYOM2	7.28e-05	192	100	5	ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PTCH1 ZAP70 LIM2 GTF3C1 MYOM2	7.28e-05	192	100	5	58a7829b411b02b422ef75e2277a868969cc23e8
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	7.28e-05	192	100	5	fd7f034f0d5a5d577dc9e26a15856f5defbdef43
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	7.28e-05	192	100	5	1922b0350d3375e67c314dbce8074e5cf986f2ef
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	7.28e-05	192	100	5	97c197643e59835c6d45dde9e549c9a1b1bb7288
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	7.28e-05	192	100	5	a4d161e3d48bc020e687808b352325ef9d1cc1f3
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	7.46e-05	193	100	5	e790ab76c12f74a13936c231076f1e397283efb3
ToppCell	ICU-SEP-Lymphocyte-T_NK-NK\|ICU-SEP / Disease, Lineage and Cell Type	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	7.46e-05	193	100	5	f110f86db305e41639087f5b1a2dff103c07adf0
ToppCell	lymphoid-NK_cell-NK_cell\|World / Lineage, cell class and subclass	DOK2 HAVCR2 LIM2 GTF3C1 MYOM2	7.65e-05	194	100	5	7f5adc18e632109694446b8eb1543cbae62dccbe
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	7.65e-05	194	100	5	7773501e076d470158dbc1d7f10c67152b326eb7
ToppCell	lymphoid-NK_cell\|World / Lineage, cell class and subclass	DOK2 HAVCR2 LIM2 GTF3C1 MYOM2	7.65e-05	194	100	5	4bf5a140be8691e4ec99d7ee15588fd48acd6fb5
ToppCell	343B-Lymphocytic-NK_cells\|343B / Donor, Lineage, Cell class and subclass (all cells)	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	7.83e-05	195	100	5	33a460624a65ba033452c74d143089e0bfac8f3d
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	7.83e-05	195	100	5	72f42f0be53a2a61f61647118b4883e752d998a5
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EPPK1 ZNF165 EVPL FREM2 ROS1	7.83e-05	195	100	5	62d369a8af2b76a2553bc8ff9cb89a133b060123
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	7.83e-05	195	100	5	49a4f58aac168fc1838bd5d2b202135cd794c28b
ToppCell	wk_20-22-Hematologic_Lymphocytic-NK-CD16+_NK\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	7.83e-05	195	100	5	7533822d2fe551f499b5b2fdec7172f56c79cb44
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16\|lymph-node_spleen / Manually curated celltypes from each tissue	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	7.83e-05	195	100	5	e756733cf48768bf40058d6cf9039e52f7563133
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	8.03e-05	196	100	5	5b5cf6f70534661d694f47359b6595b4580876c3
ToppCell	lymphoid-NK_cell-NK_cell\|lymphoid / Lineage, cell class and subclass	DOK2 HAVCR2 LIM2 GTF3C1 MYOM2	8.03e-05	196	100	5	5e6238fe131e349013c60a73c99f84a6be7955ef
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-NK_CD16\|bone_marrow / Manually curated celltypes from each tissue	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	8.03e-05	196	100	5	a3b077e82b1550eb328c84b567b60179001f9a77
ToppCell	10x5'-bone_marrow-Lymphocytic_NK\|bone_marrow / Manually curated celltypes from each tissue	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	8.03e-05	196	100	5	1868ad537b7f04cdad0a0c8282aadbc4f257a722
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-NK_dim-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZAP70 HAVCR2 LIM2 GTF3C1 MYOM2	8.22e-05	197	100	5	76304df40f87224f8e415677e3ee8fb183fe0c03
ToppCell	356C-Lymphocytic-NK_cells\|356C / Donor, Lineage, Cell class and subclass (all cells)	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	8.22e-05	197	100	5	ae55ac5c714e55061d605dee030cbe29b43cf9c1
ToppCell	normal-na-Lymphocytic_NK-natural_killer_cell-female\|normal / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	8.22e-05	197	100	5	994d3289a5dd1a89fbcf28a6263e3784ccf732df
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAT4 ZAP70 HAVCR2 LIM2 MYOM2	8.22e-05	197	100	5	bc37b8919f98dc18c2200834405f06823d965d78
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOK2 PTCH1 ZAP70 GTF3C1 MYOM2	8.22e-05	197	100	5	2abe27f6722fa0dab801bca4cd19e34c1fb4173e
ToppCell	BLOOD--(0)_NK_cell\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	8.22e-05	197	100	5	ce35c3ba6db897235d0107fa7dadc5013bf4da24
ToppCell	BLOOD--(0)_NK_cells_(CD56dim-like)\| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	8.22e-05	197	100	5	4c15b3386b89191af9332738e597549e2305de26
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DOK2 ZAP70 HAVCR2 GTF3C1 MYOM2	8.22e-05	197	100	5	c7cd7960e8f022b1db49485ff153675827efa35e
ToppCell	normal-na-Lymphocytic_NK-natural_killer_cell\|normal / PBMC cell types (v2) per disease, treatment status, and sex	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	8.22e-05	197	100	5	73a33d8b27043ba3074d04bc2d18cd287e00117f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOK2 ZAP70 HAVCR2 LIM2 MYOM2	8.22e-05	197	100	5	b6689a3e01e4c285fc2cb33f8c437078722a3892
ToppCell	Healthy_donor-NK\|World / disease group, cell group and cell class (v2)	DOK2 ZAP70 LIM2 GTF3C1 MYOM2	8.42e-05	198	100	5	4c9c40e91173836ad0df2eba635a4cb3385e80c6
Disease	sexual dimorphism measurement	DIP2B COL7A1 EPPK1 TRA2B KCTD19 ZNF165 MYO9B INSR GRIN2A PTCH1 H4C1 PKD1 DOT1L SMOX INS-IGF2 ATP6V0A2	8.29e-07	1106	99	16	EFO_0021796
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	1.11e-05	2	99	2	DOID:0110471 (implicated_via_orthology)
Disease	vital capacity	DIP2B CYP26B1 PCDHA7 GRIN2A GMPR2 PTCH1 GRM7 IVD GABPB2 H4C1 DOT1L PARD3 SMOX SLC2A12	6.51e-05	1236	99	14	EFO_0004312
Disease	brain disease (implicated_via_orthology)	TIAM1 DROSHA	1.66e-04	6	99	2	DOID:936 (implicated_via_orthology)
Disease	neutrophil count	CUX2 ATP13A1 PCDHA7 MCM6 DOK2 ABCA7 DEFA5 LIM2 BNIP3 GTF3C1 GABPB2 ERAP2 PKD1 ATP6V0A2	2.09e-04	1382	99	14	EFO_0004833
Disease	lung volume	TRA2B PTCH1	3.08e-04	8	99	2	EFO_0600046
Disease	supraventricular ectopy	KIF6 SCN10A	3.95e-04	9	99	2	EFO_0009277
Disease	heart rate response to exercise	CPNE5 SCN10A SMOX	4.10e-04	43	99	3	EFO_0009184
Disease	developmental disorder of mental health (implicated_via_orthology)	SIN3B GRIN2A PARD3	6.03e-04	49	99	3	DOID:0060037 (implicated_via_orthology)
Disease	myeloid white cell count	ATP13A1 MCM6 ABCA7 DEFA5 GTF3C1 PKD1 POLR1B DOT1L DNAJC5B VAV2	1.21e-03	937	99	10	EFO_0007988
Disease	Glycogen storage disease	PHKA1 AGL	1.47e-03	17	99	2	cv:C0017919
Disease	Depression, Bipolar	MAOA ANK3 GRIN2A	2.41e-03	79	99	3	C0005587
Disease	Mood Disorders	MAOA ANK3 GRIN2A SMOX	2.51e-03	168	99	4	C0525045
Disease	colorectal cancer, hormone replacement therapy	CUX2 TRA2B INSR	3.27e-03	88	99	3	EFO_0003961, MONDO_0005575

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSTEGVRAYLVLRAD	CHTF18	181	Q8WVB6
RRSSDIISLLVSIYG	ANAPC2	496	Q9UJX6
LGRETGTRYLVTALI	CHTF8	86	P0CG13
TEISREGARVLALGY	ATP13A1	676	Q9HD20
IVDRYSGDLRVASAL	FAT4	1576	Q6V0I7
RERAYGSSGELITSL	DOT1L	851	Q8TEK3
LKRRYGLISTGSDSE	CUX2	1131	O14529
RTLSTTGEALYEILG	DNAJC5B	11	Q9UF47
DTRLAELRLTGYGIS	ABCA7	1121	Q8IZY2
GRSVLYLTGVDISLE	PADI1	106	Q9ULC6
EYRTTRVSREGGVLK	ISYNA1	26	Q9NPH2
TGGVLIDRYGRRTAI	SLC2A12	96	Q8TD20
RIESTLDGSRLYITG	KCTD19	306	Q17RG1
TGITYLRVRSLPGED	PEX10	196	O60683
VLEARDRVGGRTYTI	MAOA	41	P21397
SYSLVELRVGERALS	PCDHA7	491	Q9UN72
SGVIVLTGRLDYLET	FAT1	201	Q14517
YETEGIRGLRALGVR	MCM6	276	Q14566
LRGSYTLRAGESALE	DOK2	166	O60496
LAIYTGVTVSFLGRR	LIM2	116	P55344
RISGLIYEETRGVLK	H4C1	46	P62805
RTGDIALAYRLTDLG	MAP10	171	Q9P2G4
SRTEGYIGVLIDDLT	MTO1	466	Q9Y2Z2
ERSATVRELLTELYG	PHKA1	801	P46020
GTLRLDTLSGLRYLD	CYP26B1	341	Q9NR63
LKRRGYLGETSFISI	FREM2	1791	Q5SZK8
ILDSGIYRIISSRRG	HPS5	446	Q9UPZ3
GGIVDLLSRERYSVH	EVPL	1866	Q92817
LERTGYTLDVTTGQR	HNRNPR	131	O43390
VGRYLRELSGSGLER	COG8	46	Q96MW5
TGLAVESIKTVYRGR	DIP2B	831	Q9P265
TITGGAERYSDRGII	KIF6	106	Q6ZMV9
RDILGGIRSTCTYVG	GMPR2	306	Q9P2T1
GLIEEISGYLKIRRS	INSR	386	P06213
AEYRVRLGALRLGST	PRSS33	86	Q8NF86
ESLSGVCEISGRLYR	DEFA5	76	Q01523
KLYEIGAGTSEVRRL	IVD	401	P26440
GRDARSSITGVYRII	NIM1K	376	Q8IY84
YRGILRAVRGSVSTE	GPR4	201	P46093
ISSVYEIRERLGSGA	PNCK	11	Q6P2M8
IEARGLKSEGLYRVS	CHN2	301	P52757
VRASGRELSYVLLTG	GRM6	616	O15303
AIGLGIYIGRRLTTS	BNIP3	176	Q12983
VTVSGCRRLTDRGLY	FBXL7	191	Q9UJT9
GIARRLGYISVVDTL	ANK3	801	Q12955
KSTYRTLGGETRILA	ERAP2	181	Q6P179
VRASGRELSYVLLTG	GRM7	621	Q14831
IRGLEGGVSYSVRVT	COL7A1	831	Q02388
GATVYITGRHLDTLR	DHRS1	31	Q96LJ7
GIDGILEAYHRSLRT	CPNE5	411	Q9HCH3
QGLEYRGRRVTTELV	INS-IGF2	131	F8WCM5
LVLRRGVLRDGEGYT	PKD1	2431	P98161
ERRISHSLYSGIEGL	PARD3	711	Q8TEW0
GYSVTDAVALRVRSG	FIBP	26	O43427
DRFLVGGYLSSRVLL	MIEF2	241	Q96C03
LEVTLTRRGYLGETS	FREM3	1791	P0C091
YSTAEVLLRAGVSRD	GABPB2	51	Q8TAK5
AYTVLTRIGLETSLR	RUVBL2	386	Q9Y230
SYELRRDGTIVYTGL	USH2A	4476	O75445
GDSTVVGTSRLRDLY	DROSHA	431	Q9NRR4
ERRLTLGGIYKFITE	FOXE1	71	O00358
YSGLEQELGTLRETL	PLEKHA4	451	Q9H4M7
RALRSLVLGGTYRVT	FBXL12	176	Q9NXK8
DLRDSGATIRIGIYI	HAVCR2	191	Q8TDQ0
DLLSRYRAGTLTVEE	EPPK1	3006	P58107
YRAGTLTVEELGATL	EPPK1	3011	P58107
RYRAGTLTVEELGAT	EPPK1	3541	P58107
DLLSRYRAGTLTVEE	EPPK1	4071	P58107
YRAGTLTVEELGATL	EPPK1	4076	P58107
GIRRDGTLVTGYLSE	NAGPA	171	Q9UK23
TALLLSRDGRTLYVG	SEMA4B	71	Q9NPR2
LGVSLYGTTRVRDGL	PTCH1	761	Q13635
YGTTRVRDGLDLTDI	PTCH1	766	Q13635
SLGGTSEVIQRRAIY	SIN3B	531	O75182
DSITYREVLESGLAR	SHOX	31	O15266
ELALRLTEYSRTLSG	CCT4	431	P50991
LRTIVREEGAVRGLY	SLC25A42	271	Q86VD7
EGRRSVLRTIGEYLE	STRC	666	Q7RTU9
GRVAYELLGVLRSSG	STRC	971	Q7RTU9
RYLLVVSTREGEGLS	SSH3	126	Q8TE77
IAAYLGRVRTTTIGE	CLCNKA	176	P51800
VLTSGDTLYGLAERV	VPS50	716	Q96JG6
RSLGGYVLSLVHDVR	ZAP70	41	P43403
SLSSVEEDGIRRLYV	TIAM1	861	Q13009
ILLGDREISAGISSY	PJVK	61	Q0ZLH3
YVGTAIDLRGISGLR	SCN10A	201	Q9Y5Y9
TGLGPVDRVETTRRY	PFAS	111	O15067
SSASGIEILAIERYL	TBC1D23	661	Q9NUY8
LRITRLTLEDSGTYE	NPTN	101	Q9Y639
ETTDGERSVGRISLY	SMOX	101	Q9NWM0
YSLVSRELRGIIRGL	TMEM214	171	Q6NUQ4
VSDLRIFYRGSGLIS	ROS1	356	P08922
ILAGSVDGRVRRYDL	WDR83	166	Q9BRX9
RIISGRISGYISEAS	ZNF165	206	P49910
EGRRSVLRTIGEYLE	STRCP1	666	A6NGW2
GRVAYELLGVLRSSG	STRCP1	971	A6NGW2
SLREGDVVRIYSRIG	VAV2	836	P52735
TERLYSGISGLELEA	POLR1B	976	Q9H9Y6
QTYDLIERRGTKGIS	GTF3C1	371	Q12789
ILIVGRESGTIQRYS	WDR35	516	Q9P2L0
GVFGLSLYTTERDLR	TRA2B	121	P62995
RVGLRVDTTYGVLLL	ATP6V0A2	776	Q9Y487
ALRGILLITGRYVEA	AGL	1106	P35573
ALLRGSDSSYVRELI	MYO9B	661	Q13459
VTGLIEGRSYIFRVR	MYOM1	571	P52179
GLYTLRIVSRGGVSD	MYOM2	351	P54296
YSLEARVRDGIGILT	GRIN2A	286	Q12879